Replies to post #24484 on Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Key Contact Name: William Gartner (GCDx)

Phone: [phone]

Maybe He will answer it on the first ring- he did for me. Good luck and let us know if he answered any of your questions.

[Gold Seeker]

Jim, Gartners original pitch when he attempted financing was to begin selling the DR70 test very soon after financing was obtained. The FDA has now made that impossible. There is no way at all for him to begin selling cancer diagnostic tests without the FDA stepping in and making him conduct expensive trials or just shutting him down.

He obviously is not paying as much attention to the project anymore because he has not even maintained current corporation filings nor did he pay his bill with Go Daddy. That is what that was all about. He just failed to pay the hosting fee.

If Gartner could somehow find financing from a foolish investor, he would indeed proceed because that was his plan in the first place. Pay himself a good salary while the investment money lasts.